Centurion Patentors as of May 13, 2025

Robert Baldemair

Principal Researcher at Ericsson.

Patent №: 12301519 – Aperiodic scheduling request.

A user equipment (UE) in an NR TDD system checks if HARQ-ACK info is available and if an SR-PUCCH is present in a slot. If not, it generates a scheduling request (SR), appends it to the HARQ-ACK, and transmits both together.

Patent №: 12301398 – Systems and methods for phase noise tracking reference signal sequence generation using demodulation reference signals. A user equipment in a cellular network maps a demodulation reference signal (DMRS) to a PNT-RS for data transmission. It generates a DMRS resulting signal from one resource element and copies it to another, then transmits data using both the DMRS and PNT-RS.

Jeremy Edward Goodsitt

Founding Lead Machine Learning Engineering at IP Copilot.

Patent №: 12302205 – Activation of short-range wireless communication via remote activation signal.

A device receives an activation signal and checks if it matches a predefined Bluetooth activation pattern. If matched, it enables Bluetooth and communicates with another wireless device.

Patent №: 12299583 – Systems and methods for expanding data classification using synthetic data generation in machine learning models. Systems and methods classify data by first training a model on initial data. When new class data is received, a synthetic data generator creates samples for the new class, which are then used to retrain the classification model.

Guodong Zhang

Sr. Director of Wireless Research at InterDigital Inc..

Patent №: 12302401 – Apparatus, system and method for performing two-step RACH.

A wireless device triggers a RACH procedure, selects a two-step RACH type, chooses a MsgA transmission resource, sends MsgA, and waits for a network response.

Patent №: 12301515 – Method and apparatus for power control of sounding reference signal (SRS) transmission. Methods and apparatus are provided for controlling SRS power in WTRUs using carrier aggregation, TDM, and MIMO. They also address SRS overhead reduction and efficient power management.

Harpreet Singh

Chief Executive Officer at Immatics.

Patent №: 12297254 – Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers.

This invention involves using peptides, proteins, nucleic acids, and cells in cancer immunotherapy. It focuses on tumor-associated T-cell epitopes for vaccines, T-cell stimulation, or as targets for antibodies and other binding molecules

Patent №: 12297245 – Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers. This invention involves peptides, proteins, nucleic acids, and cells for cancer immunotherapy. It focuses on tumor-associated T-cell epitopes for use in vaccines or T-cell stimulation, and as targets for antibodies or other binding molecules.